Viral Vector Production (Research-Use) Global Market Report 2026
상품코드:1957920
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
바이러스 벡터 제조산(연구 용도) 시장 규모는 최근 급성장하고 있습니다. 2025년 17억 7,000만 달러에서 2026년에는 20억 4,000만 달러에 이르고, CAGR 15.2%의 성장이 전망되고 있습니다. 지난 수년간의 성장 요인으로는 유전자 치료 연구에 대한 투자 증가, 학술 연구 및 중개 연구 프로그램 확대, 첨단 세포 배양 기술의 보급, 종양학 연구에서의 바이러스 벡터 사용 증가, 위탁 연구 활동의 확대 등을 꼽을 수 있습니다.
바이러스 벡터 제조산(연구 용도) 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 35억 6,000만 달러에 이르고, CAGR은 14.9%를 나타낼 전망입니다. 예측 기간 동안의 성장은 차세대 유전자 도입 도구에 대한 수요 증가, 실험실 자동화 확산, CRISPR 및 유전자 편집 연구 확대, 학계와 바이오 제약 산업 간의 협력 강화, 재현성 및 표준화에 대한 집중도 강화에 기인할 것으로 보입니다. 예측 기간의 주요 동향으로는 확장 가능한 바이러스 벡터 제조 플랫폼의 도입 증가, 고순도 연구용 벡터 수요 증가, 부유 세포 배양 시스템의 활용 확대, 자동화된 업스트림 및 다운스트림 공정의 처리 확대, 벡터 특성 평가 및 품질 관리에 대한 집중 강화 등을 들 수 있습니다.
유전성 질환 증가 추세는 바이러스 벡터 제조산(연구용) 시장 확대를 견인할 것으로 예측됩니다. 유전성 질환은 개인의 DNA 이상에 의해 발생하는 상태나 질병을 말하며, 부모 중 한 쪽 또는 양쪽 부모로부터 물려받거나 새로운 돌연변이에 의해 발생할 수 있습니다. 이러한 유전성 질환 증가는 부모의 고령화에 기인하며, 이로 인해 돌연변이가 자손에게 전달될 가능성이 높아졌습니다. 유전성 질환의 발생률 증가는 질병 경로를 규명하고 치료 전략을 모색하기 위해 고도의 유전자 도입 시스템이 필요하기 때문에 바이러스 벡터 제조산(연구용) 시장을 촉진하고 있습니다. 예를 들어, 2024년 11월 미국 질병통제예방센터(CDC)는 21번 삼염색체증(다운증후군)은 출생아 약 643명당 1명꼴로 발생하며 연간 약 5,713명이 발생하는 반면, 18번 삼염색체증은 출생아 약 3,336명당 1명꼴로 발생하며 연간 약 1,101명이 발생한다고 보고했습니다. 연간 약 1,101건의 사례가 발생한다고 보고했습니다. 따라서 유전성 질환 증가 추세는 바이러스 벡터 제조산(연구용) 시장의 성장을 가속화할 것으로 예측됩니다.
바이러스 벡터 제조산 시장의 주요 기업들은 바이러스 벡터 제조산 효율 향상, 바이러스 벡터 수율 증가, 연구 목적의 품질 안정화를 위해 특수 세포 배양 배지 등 첨단 솔루션을 우선적으로 도입하고 있습니다. 세포배양배지는 세포를 자연환경 밖에서 성장 및 유지시키는 영양이 풍부한 배지로, 특정 세포종 및 용도에 맞게 조정된 아미노산, 비타민, 성장인자 등의 주요 성분을 함유하고 있습니다. 예를 들어, 2023년 1월, 미국에 본사를 둔 생명과학 기업 FUJIFILM Irvine Scientific은 AAV 바이러스 벡터 제조산에서 HEK293 현탁 배양에 최적화된 최초의 화학적으로 정의된 영양 배지 'BalanCD HEK293'을 출시했습니다. Viral Feed'를 출시하였습니다. 본 제품은 아데노부수체 바이러스(AAV)의 수율을 크게 증가시키는 것을 목표로 하며, 기초 배지 대비 바이러스 포장 효율을 최대 67%까지 향상시킵니다. 본 배지는 확장 가능한 유전자 치료 및 생명공학 공정에 적합하며, 다양한 포맷으로 신뢰할 수 있는 결과를 제공하고, 다양한 배지 시스템과 호환성을 갖추고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
Viral vector production for research purposes involves the lab-based creation of engineered viruses that effectively transport genetic material into target cells during experiments. These vectors get modified to become replication-incompetent and secure within controlled research settings. The workflow includes designing the vector, producing it in host cells, and purifying it to guarantee quality, safety, and efficacy for scientific applications.
The primary types of viral vector production for research purposes include adeno-associated virus (AAV), lentivirus, adenovirus, retrovirus, and others. Adeno-associated viruses are small viruses that deliver genetic material into cells; they belong to the Parvoviridae family and cannot replicate on their own, depending instead on helper viruses. Various production approaches encompass transient transfection, stable cell lines, viral packaging systems, and additional methods across workflows such as upstream processing and downstream processing. Key applications span gene therapy, vaccines, oncology, infectious diseases, and more, serving end-users like pharmaceutical and biopharmaceutical companies as well as research institutes.
Tariffs are impacting the viral vector production (research-use) market by increasing costs of imported bioreactors, cell culture media, plasmids, filtration systems, and analytical instruments required for vector manufacturing and purification. Research laboratories and biopharmaceutical research centers in North America and Europe are most affected due to reliance on imported high-precision equipment and consumables, while Asia-Pacific faces higher costs for research infrastructure expansion. These tariffs are increasing operational expenses and lengthening procurement cycles for research institutions. However, they are also encouraging local sourcing of consumables, domestic manufacturing of laboratory equipment, and regional capacity building for research-grade vector production.
The viral vector production (research-use) market research report is one of a series of new reports from The Business Research Company that provides viral vector production (research-use) market statistics, including viral vector production (research-use) industry global market size, regional shares, competitors with a viral vector production (research-use) market share, detailed viral vector production (research-use) market segments, market trends and opportunities, and any further data you may need to thrive in the viral vector production (research-use) industry. This viral vector production (research-use) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The viral vector production (research-use) market size has grown rapidly in recent years. It will grow from $1.77 billion in 2025 to $2.04 billion in 2026 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to increasing investment in gene therapy research, expansion of academic and translational research programs, availability of advanced cell culture technologies, rising use of viral vectors in oncology studies, growth of contract research activities.
The viral vector production (research-use) market size is expected to see rapid growth in the next few years. It will grow to $3.56 billion in 2030 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to increasing demand for next-generation gene delivery tools, rising adoption of automation in research laboratories, expansion of CRISPR and gene editing research, growing collaboration between academia and biopharma, increasing focus on reproducibility and standardization. Major trends in the forecast period include increasing adoption of scalable viral vector manufacturing platforms, rising demand for high-purity research-grade vectors, growing use of suspension cell culture systems, expansion of automated upstream and downstream processing, enhanced focus on vector characterization and quality control.
The increasing prevalence of genetic disorders is anticipated to drive expansion in the viral vector production (research-use) market. Genetic disorders are conditions or illnesses resulting from anomalies in an individual's DNA, which may be inherited from one or both parents or arise from novel mutations. This uptick in genetic disorders stems from older parental ages, which heighten the chances of mutations being transmitted to children. The escalating incidence of genetic disorders bolsters the viral vector production (research-use) market by fueling the need for sophisticated gene delivery systems to investigate disease pathways and explore therapeutic strategies. For instance, in November 2024, the Centers for Disease Control and Prevention (CDC), a U.S. government public health organization, reported that Trisomy 21 (Down syndrome) affects roughly 1 in 643 births, leading to about 5,713 cases each year, while Trisomy 18 impacts about 1 in 3,336 births, or around 1,101 annual cases. Thus, the growing incidence of genetic disorders is poised to accelerate growth in the viral vector production (research-use) market.
Major companies in the viral vector production market are prioritizing advanced solutions, like specialized cell culture media, to enhance transfection efficiency, boost viral vector yields, and maintain consistent quality for research purposes. Cell culture media serve as nutrient-rich formulations that support cell growth and maintenance outside their natural setting. They include key ingredients such as amino acids, vitamins, and growth factors tailored to particular cell types and uses. For example, in January 2023, FUJIFILM Irvine Scientific, a US-based life sciences firm, launched BalanCD HEK293 Viral Feed, the first chemically defined nutrient feed optimized for HEK293 suspension cultures in AAV viral vector production. This product seeks to greatly increase adeno-associated virus (AAV) yields, achieving up to a 67% gain in viral packaging efficiency over basal media. The feed suits scalable gene therapy and biotech processes, delivering reliable results across various formats and compatibility with diverse media systems.
In January 2024, Oxford Biomedica Plc, a UK-based gene and cell therapy firm, purchased ABL Europe for an undisclosed sum. Through this acquisition, Oxford Biomedica seeks to broaden its footprint in the European market and strengthen its contract development and manufacturing organization (CDMO) services, especially in viral vector production. ABL Europe, based in France, focuses on developing and manufacturing viral vectors.
Major companies operating in the viral vector production (research-use) market are Sanofi S.A., Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Lonza Group AG, Sartorius AG, Charles River Laboratories International Inc., FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Curia Inc., AGC Biologics GmbH, SK pharmteco Inc., Oxford Biomedica Plc, Waisman Biomanufacturing, Voyager Therapeutics Inc., FinVector Oy, Batavia Biosciences BV., GENEZEN LABORATORIES, BioNTech IMFS GmbH, VGXI Inc., Tonix Pharmaceuticals, Cell and Gene Therapy Catapult, Mustang Bio Inc.
North America was the largest region in the virtual vector production (research-use) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral vector production (research-use) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the viral vector production (research-use) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The viral vector production (research-use) market consists of sales of baculovirus, herpes simplex virus (HSV), vaccinia virus, vesicular stomatitis virus (VSV), hybrid viral vectors, and measles virus vectors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Viral Vector Production (Research-Use) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses viral vector production (research-use) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for viral vector production (research-use) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The viral vector production (research-use) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Type: Adeno-Associated Virus (AAV); Lentivirus; Adenovirus; Retrovirus; Other Types
2) By Production: Transient Transfection; Stable Cell Line; Viral Packaging System; Other Production Methods
3) By Workflow: Upstream Processing; Downstream Processing
4) By Application: Gene Therapy; Vaccines; Oncology; Infectious Diseases; Other Applications
5) By End-Use: Pharmaceutical And Biopharmaceutical Companies; Research Institutes
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Increasing Adoption Of Scalable Viral Vector Manufacturing Platforms
4.2.2 Rising Demand For High-Purity Research-Grade Vectors
4.2.3 Growing Use Of Suspension Cell Culture Systems
4.2.4 Expansion Of Automated Upstream And Downstream Processing
4.2.5 Enhanced Focus On Vector Characterization And Quality Control
5. Viral Vector Production (Research-Use) Market Analysis Of End Use Industries
5.1 Pharmaceutical Companies
5.2 Biopharmaceutical Companies
5.3 Academic Research Institutes
5.4 Contract Research Organizations
5.5 Government Research Laboratories
6. Viral Vector Production (Research-Use) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Viral Vector Production (Research-Use) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Viral Vector Production (Research-Use) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Viral Vector Production (Research-Use) Market Size, Comparisons And Growth Rate Analysis
7.3. Global Viral Vector Production (Research-Use) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Viral Vector Production (Research-Use) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Viral Vector Production (Research-Use) Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Viral Vector Production (Research-Use) Market Segmentation
9.1. Global Viral Vector Production (Research-Use) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Adeno-Associated Virus (AAV), Lentivirus, Adenovirus, Retrovirus, Other Types
9.2. Global Viral Vector Production (Research-Use) Market, Segmentation By Production, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Transient Transfection, Stable Cell Line, Viral Packaging System, Other Production Methods
9.3. Global Viral Vector Production (Research-Use) Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Upstream Processing, Downstream Processing
9.4. Global Viral Vector Production (Research-Use) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Gene Therapy, Vaccines, Oncology, Infectious Diseases, Other Applications
9.5. Global Viral Vector Production (Research-Use) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pharmaceutical And Biopharmaceutical Companies, Research Institutes
9.6. Global Viral Vector Production (Research-Use) Market, Sub-Segmentation Of Adeno-Associated Virus, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.7. Global Viral Vector Production (Research-Use) Market, Sub-Segmentation Of Lentivirus, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.8. Global Viral Vector Production (Research-Use) Market, Sub-Segmentation Of Adenovirus, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.9. Global Viral Vector Production (Research-Use) Market, Sub-Segmentation Of Retrovirus, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.10. Global Viral Vector Production (Research-Use) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10. Viral Vector Production (Research-Use) Market Regional And Country Analysis
10.1. Global Viral Vector Production (Research-Use) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Viral Vector Production (Research-Use) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Viral Vector Production (Research-Use) Market
11.1. Asia-Pacific Viral Vector Production (Research-Use) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Viral Vector Production (Research-Use) Market, Segmentation By Type, Segmentation By Production, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Viral Vector Production (Research-Use) Market
12.1. China Viral Vector Production (Research-Use) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Viral Vector Production (Research-Use) Market, Segmentation By Type, Segmentation By Production, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Viral Vector Production (Research-Use) Market
13.1. India Viral Vector Production (Research-Use) Market, Segmentation By Type, Segmentation By Production, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Viral Vector Production (Research-Use) Market
14.1. Japan Viral Vector Production (Research-Use) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Viral Vector Production (Research-Use) Market, Segmentation By Type, Segmentation By Production, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Viral Vector Production (Research-Use) Market
15.1. Australia Viral Vector Production (Research-Use) Market, Segmentation By Type, Segmentation By Production, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Viral Vector Production (Research-Use) Market
16.1. Indonesia Viral Vector Production (Research-Use) Market, Segmentation By Type, Segmentation By Production, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Viral Vector Production (Research-Use) Market
17.1. South Korea Viral Vector Production (Research-Use) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Viral Vector Production (Research-Use) Market, Segmentation By Type, Segmentation By Production, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Viral Vector Production (Research-Use) Market
18.1. Taiwan Viral Vector Production (Research-Use) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Viral Vector Production (Research-Use) Market, Segmentation By Type, Segmentation By Production, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Viral Vector Production (Research-Use) Market
19.1. South East Asia Viral Vector Production (Research-Use) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Viral Vector Production (Research-Use) Market, Segmentation By Type, Segmentation By Production, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Viral Vector Production (Research-Use) Market
20.1. Western Europe Viral Vector Production (Research-Use) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Viral Vector Production (Research-Use) Market, Segmentation By Type, Segmentation By Production, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Viral Vector Production (Research-Use) Market
21.1. UK Viral Vector Production (Research-Use) Market, Segmentation By Type, Segmentation By Production, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Viral Vector Production (Research-Use) Market
22.1. Germany Viral Vector Production (Research-Use) Market, Segmentation By Type, Segmentation By Production, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Viral Vector Production (Research-Use) Market
23.1. France Viral Vector Production (Research-Use) Market, Segmentation By Type, Segmentation By Production, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Viral Vector Production (Research-Use) Market
24.1. Italy Viral Vector Production (Research-Use) Market, Segmentation By Type, Segmentation By Production, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Viral Vector Production (Research-Use) Market
25.1. Spain Viral Vector Production (Research-Use) Market, Segmentation By Type, Segmentation By Production, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Viral Vector Production (Research-Use) Market
26.1. Eastern Europe Viral Vector Production (Research-Use) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Viral Vector Production (Research-Use) Market, Segmentation By Type, Segmentation By Production, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Viral Vector Production (Research-Use) Market
27.1. Russia Viral Vector Production (Research-Use) Market, Segmentation By Type, Segmentation By Production, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Viral Vector Production (Research-Use) Market
28.1. North America Viral Vector Production (Research-Use) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Viral Vector Production (Research-Use) Market, Segmentation By Type, Segmentation By Production, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Viral Vector Production (Research-Use) Market
29.1. USA Viral Vector Production (Research-Use) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Viral Vector Production (Research-Use) Market, Segmentation By Type, Segmentation By Production, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Viral Vector Production (Research-Use) Market
30.1. Canada Viral Vector Production (Research-Use) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Viral Vector Production (Research-Use) Market, Segmentation By Type, Segmentation By Production, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Viral Vector Production (Research-Use) Market
31.1. South America Viral Vector Production (Research-Use) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Viral Vector Production (Research-Use) Market, Segmentation By Type, Segmentation By Production, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Viral Vector Production (Research-Use) Market
32.1. Brazil Viral Vector Production (Research-Use) Market, Segmentation By Type, Segmentation By Production, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Viral Vector Production (Research-Use) Market
33.1. Middle East Viral Vector Production (Research-Use) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Viral Vector Production (Research-Use) Market, Segmentation By Type, Segmentation By Production, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Viral Vector Production (Research-Use) Market
34.1. Africa Viral Vector Production (Research-Use) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Viral Vector Production (Research-Use) Market, Segmentation By Type, Segmentation By Production, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Viral Vector Production (Research-Use) Market Regulatory and Investment Landscape
36. Viral Vector Production (Research-Use) Market Competitive Landscape And Company Profiles
36.1. Viral Vector Production (Research-Use) Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Viral Vector Production (Research-Use) Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Viral Vector Production (Research-Use) Market Company Profiles
36.3.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
37. Viral Vector Production (Research-Use) Market Other Major And Innovative Companies
Sartorius AG, Charles River Laboratories International Inc., FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Curia Inc., AGC Biologics GmbH, SK pharmteco Inc., Oxford Biomedica Plc, Waisman Biomanufacturing, Voyager Therapeutics Inc., FinVector Oy, Batavia Biosciences BV., GENEZEN LABORATORIES, BioNTech IMFS GmbH, VGXI Inc., Tonix Pharmaceuticals
38. Global Viral Vector Production (Research-Use) Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Viral Vector Production (Research-Use) Market
40. Viral Vector Production (Research-Use) Market High Potential Countries, Segments and Strategies
40.1 Viral Vector Production (Research-Use) Market In 2030 - Countries Offering Most New Opportunities
40.2 Viral Vector Production (Research-Use) Market In 2030 - Segments Offering Most New Opportunities
40.3 Viral Vector Production (Research-Use) Market In 2030 - Growth Strategies
